1. Market Research
  2. > Pathology Industry

Lymphoma Industry, May 2017 Market Reports from Top Publishers

You might be interested in: Diagnostics, Cancer, Therapy, Hematology Instrument, Nuclear Imaging Equipment, Pap Smear, Cancer Diagnostic, Leukemia, Transplantation, Lung Cancer, Nuclear Medicine, Blood Disease, Infectious Disease, Prostate Cancer, Specialty Hospital.


 
1-10 of about 300 reports for Lymphoma

Purchase Reports From Reputable Market Research Publishers

Lymphoma Treatment Drugs Industry Forecasts - China Focus

  • $ 1800
  • Industry report
  • May 2017
  • by Asia Market Information & Development Company

This study focuses on China’s Lymphoma Treatment Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities ...

Lymphoma Treatment Drugs Markets in China

  • $ 4000
  • Industry report
  • May 2017
  • by Asia Market Information & Development Company

China’s demand for Lymphoma Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed ...

Lymphoma Treatment Drugs Companies in China

  • $ 1800
  • Industry report
  • May 2017
  • by Asia Market Information & Development Company

This study focuses on China’s Lymphoma Treatment Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the ...

Acid Sphingomyelinase Deficiency Type C - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • May 2017
  • by Global Markets Direct

Acid Sphingomyelinase Deficiency Type C - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acid Sphingomyelinase Deficiency Type C - ...

Uveal Melanoma - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • April 2017
  • by Global Markets Direct

Uveal Melanoma - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Uveal Melanoma - Pipeline Review, H1 2017, provides an overview of ...

Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • April 2017
  • by Global Markets Direct

Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Graft Versus Host Disease (GVHD) – Pipeline Review, ...

Post-Polycythemia Vera Myelofibrosis (PPV-MF) - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • April 2017
  • by Global Markets Direct

Post-Polycythemia Vera Myelofibrosis (PPV-MF) - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Post-Polycythemia Vera Myelofibrosis ...

Liver Transplant Rejection - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • April 2017
  • by Global Markets Direct

Liver Transplant Rejection - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Liver Transplant Rejection – Pipeline Review, H1 2017, ...

The 2018-2023 World Outlook for non-Hodgkin Lymphoma (NHL) Therapeutics

  • $ 995
  • Industry report
  • April 2017
  • by ICON Group

This study covers the world outlook for non-Hodgkin lymphoma (NHL) therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry ...

The 2018-2023 World Outlook for Lymphoma Therapeutics

  • $ 995
  • Industry report
  • April 2017
  • by ICON Group

This study covers the world outlook for lymphoma therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), ...

About 6500 reports for Lymphoma

Download Unlimited Documents from Trusted Public Sources

Therapy Market and Lymphoma Statistics in the UK

  • July 2016
    182 pages
  • Therapy  

    Lymphoma  

    Chemotherapy  

  • United Kingdom  

View report >

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.